Angiotensin-converting enzyme insertion/deletion polymorphism and cerebrovascular disease

Stroke

Volumn 27, Issue 3, 1996, Pages 435-440

  Catto, Andrew ^a   Carter, Angela M ^a   Barrett, Jennifer H ^a   Stickland, Max ^a   Bamford, John ^b   Davies, J Andrew ^a   Grant, Peter J ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

angiotensin converting enzymes; cerebrovascular disorders; genetics; mortality

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; AGED; ARTICLE; CEREBROVASCULAR DISEASE; ENZYME BLOOD LEVEL; FEMALE; GENE DELETION; GENE INSERTION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STROKE;

EID: 0029923601     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.27.3.435     Document Type: Article

References (33)

1. Erdös EG, Skidgel RA. The angiotensin I-converting enzyme. Lab Invest. 1987;56:345-348.
2. Ehlers MRW, Riordan JF. Angiotensin-converting enzyme: new concepts concerning its biological role. Biochemistry. 1989;28: 5311-5316.
3. McGeer EG, Singh EA. Angiotensin-converting enzyme in cortical tissue in Alzheimer's and some other neurological diseases. Dementia. 1992;3:299-303.
4. Strittmatter SM, Thiele EA, Kapiloff MS, Snyder SH. A rat brain isoenzyme of angiotensin-converting enzyme. J Biol Chem. 1985; 260:9825-9832.
5. Alhenc-Gelas F, Richard J, Courbon D, Warnet JM, Corvol P. Distribution of plasma angiotensin I-converting enzyme levels in healthy men: relationship to environmental and hormonal parameters. J Lab Clin Med. 1991;117:33-39.
6. Cambien F, Costerousse O, Tiret L, Poirier O, Lecerf L, Gonzales MF, Evans A, Arveiler D, Cambou JP, Luc G, Rakotovao R, Ducimetiere P, Soubrier F, Alhenc-Gelas F. Plasma level and gene polymorphism of angiotensin-converting enzyme in relation to myocardial infarction. Circulation. 1994;90:669-676.
7. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 1990;86:1343-1346.
8. Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, Arveiler D, Luc G, Bard JM, Bara L, Ricard S, Tiret L, Amouyel P, Alhenc-Gelas F, Soubrier F. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature. 1992;359:641-644.
9. Raynolds MV, Bristow MR, Bush EW, Abraham WT, Lowes BD, Zisman LS, Taft CS, Ferryman MB. Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy. Lancet. 1993;342:1073-1075.
10. Zingone A, Dominijanni A, Mele E, Marasco O, Melina F, Minchella P, Quaresima B, Tiano MT, Gnasso A, Pujia A, Perrotti N. Deletion polymorphism in the gene for angiotensin converting enzyme is associated with elevated fasting blood glucose levels. Hum Genet. 1994;94:207-209.
11. Jeunemaitre X, Lifton RP, Hunt SC, Williams RR, Lalouel JM. Absence of linkage between the angiotensin converting enzyme locus and human essential hypertension. Nat Genet. 1992;1:72-75.
12. Jacob HJ, Lindpaintner K, Lincoln SE, Kusumi K, Bunker RK, Mao YP, Ganten D, Dzau VJ, Lander ES. Genetic mapping of a gene causing hypertension in the stroke-prone spontaneously hypertensive rat. Cell. 1991;67:213-224.
13. Iwai N, Ohmichi N, Nakamura Y, Kinoshita M. DD genotype of the angiotensin-converting enzyme gene is a risk factor for left ventricular hypertrophy. Circulation. 1994;90:2622-2628.
14. Kupari M, Perola M, Koskinen P, Virolainen J, Karhunen PJ. Left ventricular size, mass, and function in relation to angiotensin-converting enzyme gene polymorphism in humans. Am J Physiol. 1994; 267:H1107-1111.
15. Hantano S. Experience from a multicentre stroke register: a preliminary report. Bull World Health Organ. 1976;54:541-553.
16. Rose G, McCartney P, Reid DD. Self-administration of a questionnaire on chest pain and intermittent claudication. Br J Prev Soc Med. 1977;31:42-48.
17. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet. 1991;337:1521-1526.
18. Gustincich S, Manfioletti G, Del Sal G, Scheinder C. A fast method for high-quality genomic DNA extraction from whole human blood. Biotechniques. 1991;11:298-301.
19. Shanmugam V, Sell KW, Sana BK. Mistyping ACE heterozygotes. PCR Methods Appl. 1993;3:120-121.
20. Larochelle P, Genest J, Juchel O, Bocher R, Gutkowska Y, McKinstry D. Effect of captopril (SQ 14225) on blood pressure, plasma renin activity and angiotensin-I converting enzyme activity. Can Med Assoc J. 1979;121:309-316.
21. Sassano P, Chatellier G, Billaud E, Alhenc-Gelas F, Corvol P, Menard J. Treatment of mild to moderate hypertension with or without the converting enzyme inhibitor enalapril. Am J Med. 1988; 83:227-235.
22. Syrjanen J, Teppo AM, Valtonen VV, Iivanainen M, Maury CP. Acute phase response in cerebral infarction. J Clin Pathol. 1989;42: 63-68.
23. Sharma P, Carter ND, Barley J, Lunt R, Seymour CA, Brown MM. Polymorphisms in the gene encoding angiotensin 1-converting enzyme and relationship to its post-translational product in cerebral infarction. J Hum Hypertens. 1994;8:633-634.
24. Bonithon-Kopp C, Ducimetiere P, Touboul PJ, Feve JM, Billaud E, Courbon D, Heraud V. Plasma angiotensin-converting enzyme activity and carotid wall thickening. Circulation. 1994;89:952-954.
25. Schachter F, Faure-Delanef L, Guenot F, Rouger H, Froguel P, Lesueur-Ginot L, Cohen D. Genetic associations with human longevity at the APOE and ACE loci. Nat Genet. 1994;6:29-32.
26. Markus HS, Barley J, Lunt R, Bland JM, Jeffery S, Carter ND, Brown MM. Angiotensin-converting enzyme gene deletion polymorphism: a new risk factor for lacunar stroke but not carotid atheroma. Stroke. 1995;26:1329-1333.
27. Miettinen HE, Korpela K, Hamalainen L, Kontula K. Polymorphisms of the apolipoprotein and angiotensin converting enzyme genes in young North Karelian patients with coronary heart disease. Hum Genet. 1994;94:189-192.
28. Berge KE, Bohn M, Berg K. DNA polymorphism at the locus for angiotensinogen I-converting enzyme in Norwegian patients with myocardial infarction and controls. Clin Genet. 1994;46:102-104.
29. Lindpaintner K, Pfeffer MA, Kreutz R, Stampfer MJ, Grodstein F, LaMotte F, Buring J, Hennekens CH. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med. 1995;332:706-711.
30. Nakai K, Itoh C, Miura Y, Hotta K, Musha T, Itoh T, Miyakawa T, Iwasaki R, Hiramori K. Deletion polymorphism of the angiotensin !-converting enzyme gene is associated with serum ACE concentration and increased risk for CAD in the Japanese. Circulation. 1994;90:2199-2202.
31. Mattu RK, Needham EWA, Galton DJ, Frangos E, Clark AJL, Caulfield M. A DNA variant at the angiotensin-converting enzyme gene locus associates with coronary heart disease in the Caerphilly Heart Study. Circulation. 1995;91:270-274.
32. Ruiz J, Blanche H, Cohen N, Velho G, Cambien F, Cohen D, Passa P, Froguel P. Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci U S A. 1994;91:3662-3665.
33. Zee RY, Lou YK, Griffiths LR, Morris BJ. Association of a polymorphism of the angiotensin I-converting enzyme gene with essential hypertension. Biochem Biophys Res Commun. 1992;184: 9-15.